Magnesium in biology be used as adjuvant therapy in patients on optimal treatment for severe congestive heart failure, increasing survival rate and improving clinical symptoms and patient's quality of life. Magnesium can affect muscle relaxation through direct action on cell membranes. Mg ions close certain types of calcium channels, which conduct positively charged calcium ions into neurons. With an excess of magnesium, more channels will be blocked and nerve cells activity will decrease. Intravenous magnesium sulphate is used in treating pre-eclampsia. For other than pregnancy-related hypertension, a meta-analysis of 22 clinical trials with dose ranges of 120 to 973 mg/day and a mean
Magnesium oxychloride dioxide from the air to form magnesium chlorocarbonates. Anhydrous and partially hydrated forms also absorb water, turning into phase 5 and then phase 3 on the way to the chlorocarbonate. The exceptions are the dihydrate and hexahydrate of phase 9, that remain unchanged for many months. The crystal structure of phase 3 is triclinic with space group formula_1 and "z" = 2. The solid consists polymeric aquohydroxo cations, in the form of double chains of magnesium atoms surrounded and bridged by the oxygen atoms in hydroxy groups and complexed water molecules. These linear cations are interleaved and neutralized by chloride